FDA Approves Botox Challenger Daxxify for Frown Lines

Brasil Notícia Notícia

FDA Approves Botox Challenger Daxxify for Frown Lines
Brasil Últimas Notícias,Brasil Manchetes
  • 📰 Medscape
  • ⏱ Reading Time:
  • 33 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 55%

FDA has approved daxibotulinumtoxinA-lanm injection for the temporary improvement in the appearance of moderate to severe glabellar lines in adults.

release inhibitor and neuromuscular blocking agent, is the first peptide-formulated, long-acting neuromodulator approved for this indication.

About three quarters of participants achieved at least a two-grade improvement in glabellar lines at week 4 as judged by both investigator and patient and 98% achieved"none or mild wrinkle severity" at week 4 per investigator assessment, the company said. "Compelling data from the largest phase 3 clinical program ever conducted for glabellar lines demonstrated that Daxxify was well tolerated and achieved clinically significant improvement with long-lasting results and high patient satisfaction," SAKURA investigator Jeffrey Dover, MD, co-director of SkinCare Physicians, Chestnut Hill, Massachusetts, said in the news release.

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

Medscape /  🏆 386. in US

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Revance Shares Jump 18% After FDA Approves Botox Rival DaxxifyRevance Shares Jump 18% After FDA Approves Botox Rival DaxxifyShares of Revance Therapeutics surged 18% Thursday after the company announced the Food and Drug Administration had approved Daxxify.
Consulte Mais informação »

FDA Approves New Botox RivalFDA Approves New Botox RivalThe U.S. Food and Drug Administration approved a new antiwrinkle treatment that could be the most formidable challenger to date to market leader Botox
Consulte Mais informação »

'A Disgrace': Ron Johnson Says He Opposes Same-Sex Marriage Bill'A Disgrace': Ron Johnson Says He Opposes Same-Sex Marriage Bill'He's unfit for public office,' responded progressive challenger TheOtherMandela.
Consulte Mais informação »

PolitiFact - What Herschel Walker gets wrong, and right, about federal funding for more treesPolitiFact - What Herschel Walker gets wrong, and right, about federal funding for more treesU.S. Senate candidate Herschel Walker is right about 1.5 billion being spent on efforts to bolster urban tree cover. He exaggerated when he said the bill will 'raise taxes' on middle- and lower-income Americans.
Consulte Mais informação »

Arlington Heights trustees hire consultants for financial, traffic studies of Chicago Bears’ stadium plansArlington Heights trustees hire consultants for financial, traffic studies of Chicago Bears’ stadium plansArlington Heights trustees approved hiring traffic and finance consultants for studies related redeveloping Arlington International Racecourse.
Consulte Mais informação »

Friendswood budget based on flat tax rate would still result in higher tax bills for manyFriendswood budget based on flat tax rate would still result in higher tax bills for manyFriendswood City Council has unanimously approved a $114.2 million 2023 fiscal year...
Consulte Mais informação »



Render Time: 2025-03-10 20:36:19